Priya Gokani

Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B‐cell acute lymphoblastic leukemia

Manon Queudeville, Anthony S. Stein, Franco Locatelli et al. · Cancer · 2023 · 46 citations · Full text

Medicine, Hematology, Oncology +16

A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB–IVM1a Melanoma in Four European Countries

Alexander C. J. van Akkooi, Sebastian Haferkamp, Sophie Papa et al. · Advances in Therapy · 2020 · 16 citations · Full text

Medicine, Oncology, Surgery +17

Phase 1 clinical trial of AMG 340, a prostate-specific membrane antigen (PSMA)-targeted T-cell engager with a novel low-affinity CD3 binding domain designed to mitigate toxicity for the treatment of metastatic castration-resistant prostate cancer (mCRPC).

Gerald S. Falchook, Meredith McKean, William K. Kelly et al. · Journal of Clinical Oncology · 2024 · 16 citations

Medicine, Oncology, Pharmacology +17